Anti diabetic Activity Of Green Tea And Black Tea (In Vivo)
DOI:
https://doi.org/10.26418/jft.v7i2.90374Keywords:
anti diabetic, black tea, green teaAbstract
Diabetes is a chronic medical condition that affects the way the body processes glucose. In recent years, there have been various advances in the diagnosis, management and treatment of diabetes, especially type 1 and type 2 diabetes. Green tea and black tea have long been known to have various health benefits, including potential anti diabetic effects. This article presents a review of the anti diabetic activity of green tea and black tea based on in vivo studies. Green tea, which is rich in polyphenols such as epigallocatechin-3-gallate (EGCG), is known to improve glucose tolerance and reduce insulin resistance. These effects are mediated by an increase in GLUT4 expression, as well as a reduction in insulin resistance index. Black tea with distinctive ingredients such as theaflavin and thearubigin, shows potential in inhibiting carbohydrate hydrolysis enzymes, increasing insulin secretion, and improving pancreatic function. Studies using animal models of diabetes have shown that tea consumption can lower blood glucose levels, improve glucose tolerance, and prevent damage to pancreatic beta cells. Although various studies have supported these benefits, there are inconsistencies in the results of epidemiological studies in humans. This could be due to variations in tea processing methods, tea chemical composition, as well as differences in research conditions. Therefore, further research is needed to understand the mechanisms underlying the anti diabetic effects of green tea and black tea and develop more controlled clinical applications.
References
Akalın, K., Ekiz, A. T., Karakaya, F., Karadag, A., Pelvan, E., Doğan, K., Alasalvar, C., & Aksu, S. (2019). In vivo antidiabetic activities of green and black tea polysaccharides using streptozotocin- induced diabetic mice fed with a high-fat diet. Journal of Food Bioactives, 8.
Al-Awar, A., Kupai, K., Veszelka, M., Szűcs, G., Attieh, Z., Murlasits, Z., Török, S., Pósa, A., & Varga, C. (2016). Experimental Diabetes Mellitus in Different Animal Models. Journal of Diabetes Research, 2016.
Alam, F., Shafique, Z., Amjad, S. T., & Bin Asad, M. H. H. (2019). Enzymes inhibitors from natural sources with antidiabetic activity: A review. Phytotherapy Research, 33(1), 41-54.
Almeida, T. S. de ., Araújo, M. E. M., RodrÃguez, L. G., Júlio, A., Mendes, B. G., Santos, R. M. B. dos ., & Simões, J. A. M.. (2019). Influence of preparation procedures on the phenolic content, antioxidant and antidiabetic activities of green and black teas. Brazilian Journal of Pharmaceutical Sciences, 55, e17695.
Chatterjee, S., Khunti, K., & Davies, M. J. (2017). Type 2 diabetes. The lancet, 389(10085), 2239-2251.
Dang, F., Jiang, Y., Pan, R., Zhou, Y., Wu, S., Wang, R., & Man, C. (2018). Administration of Lactobacillus paracasei ameliorates type 2 diabetes in mice. Food & Function, 9(7), 3630-3639.
Du, L. L., Fu, Q. Y., Xiang, L. P., Zheng, X. Q., Lu, J. L., Ye, J. H., & Liang, Y. R. (2016). Tea polysaccharides and their bioactivities. Molecules, 21(11), 1449.
Ferreira, G., Veening-Griffioen, D., Boon, W., Hooijmans, C., Moors, E., Schellekens, H., & Van Meer, P. (2020). Comparison of drug efficacy in two animal models of type 2 diabetes: A systematic review and meta-analysis. European journal of pharmacology, 173153.
Fu, Q. Y., Li, Q. S., Lin, X. M., Qiao, R. Y., Yang, R., Li, X. M., & Liang, Y. R. (2017). Antidiabetic effects of tea. Molecules, 22(5), 849.
Furman, B. (2015). Streptozotocinâ€Induced Diabetic Models in Mice and Rats. Current Protocols in Pharmacology, 70, 5.47.1 - 5.47.20.
Gomes, A., Vedasiromoni, J., Das, M., Sharma, R., & Ganguly, D. (1995). Anti-hyperglycemic effect of black tea (Camellia sinensis) in rat. Journal of ethnopharmacology, 45 3, 223-6.
Gosslau, A., Zachariah, E., Li, S., & Ho, C. T. (2018). Anti-diabetic effects of a theaflavin-enriched black tea extract in the obese ZDF rat model. Journal of Food Bioactives, 3, 151-160.
Holidah, D., Christianty, F. M., & Ilma, W. Z. (2017). Green tea extract effect on blood glucose level and liver histopathology in diabetic mice. UNEJ e-proceeding, 35-38.
Huang, J., Xie, Z., Wang, Y., Zhang, J., & Wan, X. (2015). Recent advances of anti-hyperglycemia and anti-diabetes actions of tea in animal studies. Current Opinion in Food Science, 2, 78-83.
IDF. 2017. Diabetes atlas (8th ed). International Diabetes Federation, Brussels, pp. 43–63.
Jörns, A., Arndt, T., Vilsendorf, A., Klempnauer, J., Wedekind, D., Hedrich, H., Marselli, L., Marchetti, P., Harada, N., Nakaya, Y., Wang, G., Scott, F., Gysemans, C., Mathieu, C., & Lenzen, S. (2014). Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes. Diabetologia, 57, 512-521.
Li, B., Fu, L., Kojima, R., Yamamoto, A., Ueno, T., & Matsui, T. (2021). Theaflavins prevent the onset of diabetes through ameliorating glucose tolerance mediated by promoted incretin secretion in spontaneous diabetic Torii rats. Journal of Functional Foods.
Liu, C., Huang, C., Huang, L., Chen, I., Chiu, J., & Hsu, C. (2014). Effects of Green Tea Extract on Insulin Resistance and Glucagon-Like Peptide 1 in Patients with Type 2 Diabetes and Lipid Abnormalities: A Randomized, Double-Blinded, and Placebo-Controlled Trial. PLoS ONE, 9.
Lu, Y., Lu, P., Wang, Y., Fang, X., Wu, J., & Wang, X. (2019). A Novel Dipeptidyl Peptidase IV Inhibitory Tea Peptide Improves Pancreatic β-Cell Function and Reduces α-Cell Proliferation in Streptozotocin-Induced Diabetic Mice. International Journal of Molecular Sciences, 20.
Striegel, L., Kang, B., Pilkenton, S., Rychlik, M., & Apostolidis, E. (2015). Effect of Black Tea and Black Tea Pomace Polyphenols on α-Glucosidase and α-Amylase Inhibition, Relevant to Type 2 Diabetes Prevention. Frontiers in Nutrition, 2.
Tang, W., Li, S., Liu, Y., Huang, M., & Ho, C. (2013). Anti-diabetic activity of chemically profiled green tea and black tea extracts in a type 2 diabetes mice model via different mechanisms. Journal of Functional Foods, 5, 1784-1793.
Ueda-Wakagi, M., Nagayasu, H., Yamashita, Y., & Ashida, H. (2019). Green Tea Ameliorates Hyperglycemia by Promoting the Translocation of Glucose Transporter 4 in the Skeletal Muscle of Diabetic Rodents. International Journal of Molecular Sciences, 20.
Wang, K., Wu, J., Chen, S., Zhao, H., He, P., Tu, Y., & Li, B. (2022). Transcriptome analysis provides insight into the anti-diabetic mechanism of theaflavins in high-fat diet and streptozotocin-induced mice. Food & function.
Xia, H. M., Wang, J., Xie, X. J., Xu, L. J., & Tang, S. Q. (2019). Green tea polyphenols attenuate hepatic steatosis, and reduce insulin resistance and inflammation in high-fat diet-induced rats. International journal of molecular medicine, 44(4), 1523-1530.
Xu, L., Li, Y., Dai, Y., & Peng, J. (2018). Pharmacology and mechanisms. Pharmacol. Res, 127, 1-15.
Yin, J., Yang, L., Mou, L., Dong, K., Jiang, J., Xue, S., Xu, Y., Wang, X., Lu, Y., & Ye, H. (2019). A green tea–triggered genetic control system for treating diabetes in mice and monkeys. Science Translational Medicine, 11.
Yu, J., Song, P., Perry, R., Penfold, C., & Cooper, A. (2017). The Effectiveness of Green Tea or Green Tea Extract on Insulin Resistance and Glycemic Control in Type 2 Diabetes Mellitus: A Meta-Analysis. Diabetes & Metabolism Journal, 41, 251 - 262.
Zhang, Z., Deng, X., Chen, R., Li, Q., Sun, L., Cao, J., Lai, Z., Lai, X., Wang, Z., Sun, S., & Zhang, L. (2024). Effect of Black Tea Polysaccharides on Alleviating Type 2 Diabetes Mellitus by Regulating PI3K/Akt/GLUT2 Pathway. Foods, 13.
Zhou, H., Li, F., Wu, M., Zhu, J., Wang, Y., & Wei, X. (2023). Regulation of glucolipid metabolism and gut microbiota by green and black teas in hyperglycemic mice. Food & function.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 FoodTech: Jurnal Teknologi Pangan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
